U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H29N5O4
Molecular Weight 439.5075
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MK-0429

SMILES

COC1=CC=C(C=N1)[C@H](CC(O)=O)N2CCN(CCCC3=NC4=C(CCCN4)C=C3)C2=O

InChI

InChIKey=HGFOOLONGOBCMP-IBGZPJMESA-N
InChI=1S/C23H29N5O4/c1-32-20-9-7-17(15-25-20)19(14-21(29)30)28-13-12-27(23(28)31)11-3-5-18-8-6-16-4-2-10-24-22(16)26-18/h6-9,15,19H,2-5,10-14H2,1H3,(H,24,26)(H,29,30)/t19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C23H29N5O4
Molecular Weight 439.5075
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Renal elimination of a novel and potent alphavbeta3 integrin antagonist in animals.
2004 Nov-Dec
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:18:58 GMT 2023
Edited
by admin
on Sat Dec 16 11:18:58 GMT 2023
Record UNII
1JL033A2D0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MK-0429
Common Name English
MK-429
Code English
3-PYRIDINEPROPANOIC ACID, 6-METHOXY-.BETA.-(2-OXO-3-(3-(5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-YL)PROPYL)-1-IMIDAZOLIDINYL)-, (.BETA.S)-
Systematic Name English
J1.969.455K
Code English
(3S)-3-(6-METHOXY-3-PYRIDYL)-3-(2-OXO-3-(3-(5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-YL)PROPYL)IMIDAZOLIDIN-1-YL)PROPANOIC ACID
Systematic Name English
Code System Code Type Description
CAS
227963-15-7
Created by admin on Sat Dec 16 11:18:58 GMT 2023 , Edited by admin on Sat Dec 16 11:18:58 GMT 2023
PRIMARY
SMS_ID
100000177670
Created by admin on Sat Dec 16 11:18:58 GMT 2023 , Edited by admin on Sat Dec 16 11:18:58 GMT 2023
PRIMARY
FDA UNII
1JL033A2D0
Created by admin on Sat Dec 16 11:18:58 GMT 2023 , Edited by admin on Sat Dec 16 11:18:58 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
MK-0429
Created by admin on Sat Dec 16 11:18:58 GMT 2023 , Edited by admin on Sat Dec 16 11:18:58 GMT 2023
PRIMARY Description: MK-0429 is a potent and selective inhibitor of the .ALPHA.v.BETA.3 integrin, which showed therapeutic effects on bone turnover disease in men with hormone-refractory prostate cancer (HRPC) and bone metastases. MK-0429 was safe and efficacious in significantly decreasing melanoma metastasis in the lungs. MK-0429 may be useful for the prevention of metastatic melanoma.
PUBCHEM
9853559
Created by admin on Sat Dec 16 11:18:58 GMT 2023 , Edited by admin on Sat Dec 16 11:18:58 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
IC50
Related Record Type Details
ACTIVE MOIETY
The orally administered MK-0429 has completed a Phase I/II study in solid tumors with no reported safety issues [43]. However, no further development has been reported.